Cash and Compounding

Cash and Compounding

Accenture converts reported profit into cash at a genuinely high rate — free cash flow ran about 1.3 to 1.4 times net income across fiscal 2022–2025 [1]. Two things temper what that cash becomes for a shareholder: roughly $2 billion a year of share-based compensation flatters the cash figure and blunts buybacks, so the diluted share count has fallen only about 1.6% in three years; and a rising share of revenue growth is bought, with goodwill up 72% to $22.5 billion.

The cash is real, and low-capex is why

The starting point is not in dispute. Operating cash flow reached $11.5 billion in fiscal 2025 on capital expenditure of just $600 million — under 1% of the $69.7 billion revenue base — leaving $10.9 billion of free cash flow [2]. A people business needs offices and laptops, not fabs or networks, so nearly all of operating cash flow drops through to free cash flow. Over four years the free-cash-flow-to-net-income ratio has sat comfortably above 1.0, the signature of an asset-light model with favourable working capital.

Source: FY2025 Annual Report, Consolidated Statements of Cash Flows [3]. Net income is total net income including noncontrolling interests, as presented on the cash flow statement.

Two mechanics sit behind the strong conversion, and one deserves a second look. The benign part is working capital: clients pay in advance and against milestones, so deferred revenue rose $707 million and accrued payroll $904 million in fiscal 2025, funding the business rather than draining it [4]. The part to weigh is share-based compensation — $2.1 billion in fiscal 2025, added back to operating cash flow because it is non-cash, yet a real economic cost borne by shareholders through dilution [5]. Netting it out, cash generated without expanding the share base was closer to $8.8 billion than the headline $10.9 billion.

What actually reaches shareholders per share

Accenture returned $8.3 billion to shareholders in fiscal 2025 — $4.6 billion of buybacks and $3.7 billion of dividends [6], [7]. The dividend is unambiguous cash out the door. The buyback is where the per-share arithmetic gets less flattering than the dollar figure suggests.

Across fiscal 2023–2025, Accenture spent about $13.5 billion repurchasing roughly 43 million shares, while issuing roughly 25 million shares to employees under its equity programs [4]. The net effect on the count a shareholder actually owns a slice of: diluted weighted-average shares fell from 642.8 million to 632.4 million — about 1.6% over three years, or roughly half a percent a year [8]. Close to three-fifths of the shares bought back simply replaced shares handed to employees. The buyback is doing more to hold dilution flat than to compound value per share.

Source: diluted share count from the FY2025 Annual Report income statement; repurchase and issuance detail from the shareholders' equity statement [4], [9].

This is not a criticism of the payout — a ~4% dividend yield and a share count that at least holds flat is a reasonable return of capital. It is a correction to the reflex that a $4.6 billion buyback shrinks the company by $4.6 billion. Most of it is treading water against compensation. The read here is that per-share compounding from repurchases is modest, and the swing factor is the SBC bill: if it kept growing at the mid-single-digit pace of the last three years, buybacks would have to rise just to keep the count from drifting up.

A growing share of growth is bought

The second qualifier concerns how that growth is funded. A widening slice of Accenture's revenue growth is acquired rather than organic — the organic-versus-inorganic decomposition, and what it implies for growth durability, belongs to Where Growth Comes From; the angle here is what those deals cost and what they leave on the balance sheet.

The counterpart is a steadily rising goodwill line. Purchases of businesses ran $2.5 billion in fiscal 2023, $6.6 billion in fiscal 2024, and $1.5 billion across 23 deals in fiscal 2025 [10], [11]. Goodwill has climbed from $13.1 billion in fiscal 2022 to $22.5 billion in fiscal 2025 — about 34% of total assets [12].

Source: FY2025 Annual Report, Consolidated Balance Sheet (goodwill balances, fiscal 2022–2025) [13].

The pace is set to step up again. Guided fiscal 2026 acquisition spend began at $3 billion [14] and, after a move into operational-technology cybersecurity software, was lifted to approximately $9 billion — which would be a record year for capital deployed on deals [15]. A model that leans harder on acquisition to hit a low-single-digit growth number carries more integration and impairment risk per dollar of reported growth, which is the thread that ties this chapter back to whether today's growth is a durable base or a maturing plateau.

The evidence against the caution

Three facts cut the other way, and they are not trivial. First, there has been no goodwill impairment: management's annual test found each segment's fair value substantially above carrying value at both August 2025 and August 2024 [16]. Second, the "buy-then-grow-organically" model has a live proof point: the capital-projects business, assembled through acquisitions, is now a $1.2 billion practice that grew 49% in fiscal 2025 largely organically [17]. Deals that seed a capability the firm then compounds are different in kind from deals that rent revenue. Third, management does prune: the fiscal 2025 business-optimization charge included roughly $271 million of impairments tied to divesting two acquisitions no longer aligned with strategy [18] — a small figure against $22.5 billion of goodwill, and evidence of some discipline rather than accumulation for its own sake.

What would change the read: a goodwill impairment, or a stretch where reported growth stays low while acquisition spend and inorganic contribution climb — the fiscal 2026 ramp to ~$9 billion is the near-term test — would move the balance from "bought growth that compounds" toward "growth bought to fill an organic hole."

A balance sheet that quietly changed

One structural shift belongs in the same frame. For most of its public life Accenture carried effectively no debt. In fiscal 2025 it issued $5.0 billion of senior notes across four maturities from 2027 to 2034 [19]. The company remains net cash — $11.5 billion of cash against about $5.1 billion of total debt [20], [21] — so this is not a leverage story. It is a signal that a business generating $11 billion of free cash flow chose to add fixed-rate debt anyway, giving it dry powder for the larger acquisition programme now underway and for continued capital return without drawing down the cash it prefers to keep offshore. It is worth watching whether the borrowing becomes a habit or stays a one-time top-up.

The composite picture: the cash is real and cheaply produced, but it compounds into per-share value more slowly than the $10.9 billion headline implies — buybacks are substantially anti-dilutionary, and a widening slice of growth is acquired and now sits as goodwill on a balance sheet that has, for the first time, taken on debt to keep the engine fed. Whether that engine keeps converting bought capabilities into organic growth is the same question the moat chapter leaves open, now viewed through cash rather than competition.